Achilles Therapeutics Company Profile Get Rating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Achilles therapeutics company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Achilles Therapeutics Company Profile Get Rating Today - Breaking & Trending Today

Contrasting Mesoblast (NASDAQ:MESO) & Achilles Therapeutics (NASDAQ:ACHL)

Mesoblast (NASDAQ:MESO – Get Rating) and Achilles Therapeutics (NASDAQ:ACHL – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings. Valuation & Earnings This table compares Mesoblast and Achilles Therapeutics’ […] ....

United States , United Kingdom , City Of , Achilles Therapeutics Company Profile Get Rating , Achilles Therapeutics Plc , Mesoblast Company Profile Get Rating , Tasly Pharmaceutical Group , Pharmaceuticals Co , Get Rating , Achilles Therapeutics , Achilles Therapeutic , Given Achilles Therapeutic , Company Profile , Therapeutics Company Profile , Therapeutics Plc , Nasdaq Meso , Stock Comparison , Stock Analysis ,

Piper Sandler Cuts Achilles Therapeutics (NASDAQ:ACHL) Price Target to $10.00

Achilles Therapeutics (NASDAQ:ACHL – Get Rating) had its price objective dropped by equities research analysts at Piper Sandler from $17.00 to $10.00 in a research note issued to investors on Friday, The Fly reports. Piper Sandler’s target price suggests a potential upside of 290.63% from the stock’s previous close. Separately, Zacks Investment Research cut Achilles […] ....

Piper Sandler , Achilles Therapeutics Company Profile Get Rating , Achilles Therapeutics Plc , Geode Capital Management , Zacks Investment Research , Syncona Portfolio Ltd , Affinity Asset Advisors , Achilles Therapeutics , Get Rating , Capital Management , Asset Advisors , Therapeutics Company Profile , Therapeutics Plc , Nasdaq Achl , Lower Price Target ,

Head-To-Head Review: Achilles Therapeutics (NASDAQ:ACHL) and Outlook Therapeutics (NASDAQ:OTLK)

Achilles Therapeutics (NASDAQ:ACHL – Get Rating) and Outlook Therapeutics (NASDAQ:OTLK – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, valuation and risk. Risk and Volatility Achilles Therapeutics has a beta of […] ....

New Jersey , United States , United Kingdom , City Of , Biolexis Pte , Laboratorios Liomont , Achilles Therapeutics Company Profile Get Rating , Achilles Therapeutics Plc , Outlook Therapeutics Inc , Zhejiang Huahai Pharmaceutical Co Ltd , Outlook Therapeutics Company Profile Get Rating , Oncobiologics Inc , Achilles Therapeutics , Get Rating , Outlook Therapeutics , Outlook Therapeutic , Given Achilles Therapeutic , Therapeutics Company Profile , Therapeutics Plc , Nasdaq Achl , Stock Comparison , Stock Analysis ,

Achilles Therapeutics plc (NASDAQ:ACHL) Receives Average Rating of "Buy" from Analysts

Shares of Achilles Therapeutics plc (NASDAQ:ACHL – Get Rating) have been given a consensus rating of “Hold” by the six research firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the […] ....

Piper Sandler , Geode Capital Management , Blackrock Inc , Renaissance Technologies , Affinity Asset Advisors , Achilles Therapeutics Plc , Achilles Therapeutics Company Profile Get Rating , Citadel Advisors , Achilles Therapeutics , Get Rating , Marketbeat Ratings , Asset Advisors , Capital Management , Therapeutics Company Profile , Therapeutics Plc , Nasdaq Achl ,

Achilles Therapeutics (NASDAQ:ACHL) Announces Earnings Results, Misses Expectations By $0.04 EPS

Achilles Therapeutics (NASDAQ:ACHL – Get Rating) announced its earnings results on Tuesday. The company reported ($0.45) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.41) by ($0.04), MarketWatch Earnings reports. NASDAQ:ACHL traded up $0.16 during mid-day trading on Thursday, reaching $3.23. The company’s stock had a trading volume of 30,057 shares, compared […] ....

Piper Sandler , Geode Capital Management , Goldman Sachs Group Inc , Zacks Investment Research , Renaissance Technologies , Achilles Therapeutics Plc , Achilles Therapeutics Company Profile Get Rating , Citadel Advisors , Group Plc , Achilles Therapeutics , Get Rating , Marketwatch Earnings , Sachs Group , General Group Plc , Capital Management , Investment Research , Therapeutics Company Profile , Therapeutics Plc , Nasdaq Achl ,